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Despite advances in mapping and ablation, the long-term success of 
ventricular tachycardia (VT) ablation is moderate at best.1 The high 
recurrence rate could be attributed to either the evolving scar or 
inadequate ablation of pre-existing potential scar channels. Substrate-
based ablation strategies have been shown to be as equally effective 
as activation mapping, which is often limited by haemodynamic 
instability and non-inducibility.2 
Substrate ablation is often based on late potentials (LPs) and local 
abnormal ventricular activities (LAVAs). However, the conducting 
channels critical to VT induction/maintenance need not be active 
during sinus rhythm mapping. Decrement-evoked potential (DeEP) 
mapping is a method to unmask these critical channels and to identify 
those with the potential for unidirectional block to initiate tachycardia. 
The latest consensus document on VT ablation recommends DeEP 
mapping for substrate-based ablation.3
In the current era of high-resolution mapping, detailed mapping of 
activation wavefronts in the arrhythmia circuit is feasible. The new 
multielectrode catheters offer a new perspective on detailing the 
activation maps during sinus or paced rhythm to identify regions of 
slow conduction. Isochronal late activation mapping (ILAM) is one such 
novel method to identify areas of slow conduction during sinus rhythm.4 
However, exact relationship of the areas of slow conduction to critical 
zones of re-entry and their ability to define ablation targets has not 
been clarified with a multicentre validation study. 
The functional substrate mapping technique of ILAM also assumes 
that the slow conduction zones in sinus rhythm correspond to the 
critical isthmus in VT. This does not take into account the pivotal role of 
the initiating premature ventricular contractions (PVCs) and functional 
substrate in the induction of VT. Furthermore, the areas with slower 
conduction have an activation site dependency.5
A strategy that increases the specificity of signals to better identify 
functional substrate that interacts with potential triggers (with or 
without an activation map) would be of inherent value. This 
technique would need to identify sites that initiate the re-entry and 
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the critical components of the VT circuit. This is the role and strength 
of DeEP. 
DeEP mapping identifies the components of diseased myocardium 
that are more likely to be critical to initiating or maintaining the VT 
circuit. This is achieved by delivering an extra stimulus and 
comparing the local activation delay during steady-state conditions (S1) 
and after the extra stimuli (S2). A decrement of more than 
10 ms in the local electrogram (EGM) component has been proven to 
be highly specific for the detection of the critical sites of the VT circuit 
and thus provides a mechanistic target for substrate-based ablation. 
In this review, we focus on the birth of this concept from seminal 
panoramic intra-operative mapping of VT circuits, then take the concept 
back to the basic laboratory in silico model to understand the 
mechanism, followed by a prospective validation in a multicentre VT 
ablation trial. We also review other works that share similarities to this 
concept. Importantly, we discuss the potential of DeEP mapping in the 
atrium where there is a significant need over and above pulmonary 
vein isolation (PVI) to decrease AF burden.
Validation of Decrement-evoked 
Potential Mapping 
The concept of DeEP mapping was born from the understanding that 
the initiation of a re-entrant VT circuit is dependent upon delayed or 
decremental conduction through a critical zone of tissue.6 If this slow 
conduction occurs adjacent to a site of unidirectional block, then a re-
entrant circuit may develop.7 The concept of linking EGMs that identify 
regions displaying decremental conduction to the initiation and 
maintenance of VT is shown in Figure 1. 
The principles of the DeEP mapping strategy were initially examined 
using these simultaneous panoramic endocardial maps from 
intraoperative VT cases. These cases showed global activation of the 
left ventricular endocardium during a pacing train from the right 
ventricular apex, an extra-stimulus and VT. 
Jackson et al. examined six hearts (nine VTs) that had undergone 
simultaneous panoramic mapping for VT induction.6 In each case, a 
substrate (or voltage) map was created to identify regions of fixed 
conduction block during right ventricular pacing, an activation map of 
the VT circuit was created to identify the critical isthmus, an LP map 
was created by highlighting any regions with local activation occurring 
beyond the end of the QRS and a DeEP map was created to highlight 
any regions of the myocardium where components of the local EGM 
displayed decrement following a single extra-stimulus. These maps 
were then compared to determine the sensitivity and specificity of 
DeEPs to the critical isthmus of the VT circuit (Figure 2). In this study, the 
mean sensitivity for identifying the critical isthmus in VT was 50 ± 23% 
for DeEPs and 36 ± 32% for LPs (p=0.31). The mean specificity was 
43 ± 23% versus 20 ± 8% for DeEP and LP mapping respectively 
(p=0.031). Further to this, the EGMs that displayed the greatest 
decrement in each case had a sensitivity and specificity for the VT 
isthmus of 29 ± 10% and 95 ± 1%, respectively.6
This study showed DeEPs had better specificity than LPs for identifying 
the VT isthmus.6 Additionally, in silico simulations showed that 
conduction velocity restitution magnified by zig-zag conduction in 
diseased areas of myocardium could be the underlying mechanism for 
DeEPs. In this way, the authors were able to show that a mechanistic 
strategy that looked at functional aspects of the substrate with a single 
extra-stimulus was able to refine the conventional targets of VT ablation 
(LAVAs) to a more focused strategy. Based on data from high-resolution 
mapping of swine VT circuits, areas with the slowest conduction where 
decrement is likely to occur may correspond to wavefront curvature or 
changes in myocardial fibre orientation.8,9
In Silico Modelling of Decrement-evoked Potential 
The physiological variables that could affect the presence and extent 
of decrement had to be defined. The objective of this back-to-bench 
strategy was to understand the effect of multiple pacing parameters 
on the degree of decrement, i.e. the proximity of pacing to the 
conducting channels in the unexcitable scar, the number of 
conducting channels in the scar, the size of scar, the effect of multiple 
extrasystoles and the direction of engagement of the channels. 
Validation with an animal or human model of such a number of 
variables is not feasible so a computer model was used in the study 
by Beheshti et al.10,11
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This figure corresponds to an intraoperative panoramic mapping case of ventricular tachycardia 
(VT) induction using a 112 bipole endocardial balloon. A: EGMs A–K correspond with the bipoles 
labelled A–K in panel C. The end of a drivetrain (S1) is followed by three extra-stimuli (S2–S4) and 
the initiation of a re-entrant VT. The near-field EGMs progressively decrement with each 
extra-stimulus until unidirectional block occurs between bipoles I and J, allowing for the 
initiation of the re-entrant circuit. Most of the near-field EGMs in panel A (that occur along the 
length of the diastolic isthmus in VT) display decrement with the first extra-stimulus, hence 
these would all be considered DeEPs and would all be excellent targets for the ablation of this 
particular VT. B: An enlarged image of bipole H from panel A. C: Bull’s-eye map of the left 
ventricular endocardium showing all 112 bipoles of the balloon array with the apical electrodes 
in the centre and the basal electrodes at the periphery. The voltage has been adjusted on this 
map to show regions of fixed scar in red, and healthy voltage in dark blue. The diastolic pathway 
of the VT circuit is shown as a red arrow in this panel. †Shows the polarity of the local 
component during S1. ‡Indicates the polarity change when the VT starts. Source: Jackson et al. 
2015.6 Reproduced with permission from Wolters Kluwer Health.
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We simulated a ventricular myocardial slab of 40 mm × 20 mm × 10 mm 
with an unexcitable core with a conductivity of 0.1 S/m. The ‘scar’ 
extended from epicardium to endocardium with a thin rim of conduction 
tissue outside (Figure  3) and it contained five conducting channels 
running towards a central isthmus. These channels could be opened or 
closed as desired. The pacing sequence of S1–S2 was simulated. The 
main findings were: pacing in close proximity to the scar maximised the 
amount of decrement (Figure 3A); pacing close to the opening of the 
channels induced less decrement (Figure 3A); the larger the size of the 
scar the larger the decrement (Figure 3B); a fewer open conducting 
channels led to higher decrement (Figure 3C); and the addition of S3 did 
not cause increased decrement. 
Current evidence points to the crucial role of decrement in local 
potentials for the induction and maintenance of scar related-VT.11 The 
clinical implications of these findings are: isolated right ventricle (RV) 
pacing for VT induction might be insufficient to produce decremental 
potentials; and different sites of programmed ventricular stimulation 
(such as the RV apex, the right ventricular outflow tract and multiple left 
ventricular sites) could be used to allow the wavefront to engage the 
scar from different directions and so alter the decrement in the local 
tissue. This may be useful in patients with left ventricular leads for 
cardiac resynchronisation, as this lead could be used as an alternate 
site that may be more effective for inducing VT depending on the 
location of the patient’s scar and critical isthmus. Anter et al. also found 
that areas of slow conduction with isochronal crowding can dramatically 
change with different pacing sites and this is consistent with our 
modelling studies.5
Clinical Validation with a Multicentre 
Ventricular Tachycardia Ablation Trial 
Many substrate-based ablation strategies have been described and 
used in the past to render patients VT free. Those strategies consisted 
initially of intraoperatively peeling the whole endocardium responsible 
for the VT circuit.12 This was followed by the development of catheter-
based strategies that were initially focusing on activation mapping that 
allowed the VT isthmus to be identified and targeted in patients with 
haemodynamically stable, mappable VT. 
The fact that many patients were experiencing breakthrough arrhythmia 
episodes during follow-up led to widespread use of substrate-based 
strategies, some of them targeting LAVA, and others encircling the 
substrate to try to electrically isolate the scar or else the use of more 
aggressive endo-epicardial scar homogenisation strategies.13–15 Those 
strategies, albeit with clinically proven benefit, have lacked the ability of 
focus the ablation in areas that are truly responsible for the initiation or 
maintenance of the VT circuit. As such, they lead to ablation of areas of 
still functional myocardium that could be playing a completely 
passive role. 
In contrast with the tendency to ablate large areas of myocardium with 
abnormal signals, the finding of the higher sensitivity and specificity of 
the DeEP areas in identifying the critical VT substrate led us to design a 
focused strategy in a multicentre setting where areas with DeEP 
properties would be targeted first with radiofrequency (RF) then re-
inducibility of VT would be tested. 
The objectives of the study were twofold: to establish whether the 
methodology for DeEP mapping with an extra-stimulus is feasible with 
current electro-anatomical mapping tools; and describe the mid-term 
results of a DeEP-guided ablation strategy in terms of VT burden. The 
study included 20 consecutive patients in three institutions.16 
Substrate maps were created during RV pacing or sinus rhythm. Late 
potentials were identified via a multi-electrode mapping catheter (16 
patients) or a 3.5 mm tip catheter, and were defined as potentials with 
complex high frequency or multicomponents after or at the QRS 
offset. For all the points showing LPs, a systematic assessment for 
local decrement was performed with a drive train (S1) from the RV at 
600  ms with a single S2 (coupled at 20  ms above the ventricular 
effective refractory period [VERP]). 
Those areas were tagged in the mapping system and, in 13 VTs, the 
activation map of the tachycardia was carefully constructed with high 
density maps (Figure 4). With that information, we were able to identify 
which proportion of DeEPs were co-located with the isthmus of VT. The 
main difference with other studies was that only areas with DeEPs were 
targeted with RF ablation. Reinduction of VT was performed after DeEPs 
were eliminated. If VT was still inducible, other targets were ablated. 
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Comparison of voltage mapping, LP mapping, diastolic path of ventricular tachycardia (VT) and 
decrement evoked potential mapping. Example of left ventricle endocardial maps obtained 
during intraoperative mapping from the same patient. A shows the apex at the centre, 
anterior wall on top, inferior wall on the bottom and basal segments at the periphery. The 
voltage map highlights an area in the anterolateral wall with low voltage corresponding to 
scar. The diastolic channel of activation is located in a region (highlighted with white arrows 
and seen in the activation map) of borderline decreased voltages between two areas of 
dense scar. The LP map (where annotation of local activation time is in the late near-field 
component) highlights an area near the apex and border zone of the low-voltage area, far 
from the actual VT circuit. In contrast, the (DeEP) map corresponds to early and late isthmus 
sites in keeping with a higher specificity for identifying ablation targets for this VT. B illustrates 
the true-positive results against false-positive results to generate likelihood ratios for LPs and 
DeEPs, LPs within scar channels and points with the largest decrement or maximum DeEPs to 
identify the diastolic isthmus during VT. Mean likelihood radios of all VTs are given above with 
the 95% CIs. DeEP = decrement evoked potential; LP = late potential. Source: Jackson et al. 
2015.6 Reproduced with permission from Wolters Kluwer Health.
Figure 2: Mapping Comparisons
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Patient characteristics were typical for a VT ablation cohort: the mean 
age was 65 ±  17 years, the left ventricular ejection fraction was 
33.4 ± 11%, 95% were men, 90% had a New York Heart Association 
classification of I–II, 40% were on two antiarrhythmic drugs and six 
were in VT storm (30%). Mapping showed that conventional LPs 
accounted for 17% of the myocardium mapped (IQR 8.9%–75%) and 
DeEPs accounted for 4.8% (IQR 2.2%–26%); p<0.001). 
Most patients (80%) became non-inducible by targeting the DeEP 
areas only and further RF in those still inducible did not change the 
inducibility rate. RF time was low, with a mean of 31 minutes ± 21 
minutes. The median (IQR) VT episode burden 6  months after the 
procedure was 0 (IQR 0–2) and it was 11 (IQR 5–25) 6 months before it. 
When the locations of LPs and DeEPs with respect to the critical VT 
regions were assessed, it was found that the area under the ROC 
curve for DeEPs (0.86; 95% CI [0.82–0.88]) was significantly higher 
than that of LPs (0.79; 95% CI [0.75–0.82]). These findings indicate that 
DeEPs have a higher specificity than LPs for the detection of critical 
VT sites during stable rhythm than LPs and also encompass a smaller 
region of the myocardium. 
The main messages of this study were: DeEP mapping was a safe and 
effective strategy to differentiate the critical regions of the VT circuit 
during stable rhythm with current electro-anatomical mapping 
technology; a limited and focused RF ablation strategy yielded the 
majority of patients non-inducible and showed mid-term results 
comparable with other contemporary ablation strategies; DeEPs 
provide higher specificity than conventional LPs obtained during stable 
rhythms. These findings are of significant importance to enhance the 
capacity of the electrophysiologist to differentiate critical areas of the 
VT substrate from passive ones. 
Workflow Considerations 
Manual construction of DeEP maps using multi-electrode catheters is 
time consuming. Therefore, current efforts are directed at automating 
this process. Recent advances in technology such as the ‘replay’ 
algorithm of CARTO (Biosense Webster), the ‘turbomap’ feature of NavX 
Ensite (Abbott) and the customised mapping window of the Rhythmia 
HDx (Boston Scientific) mapping system could aid in the creation of 
DeEP maps.
Window of Interest and Annotation Criteria
DeEP mapping might appear cumbersome initially. The key technique is 
to localise the areas of LPs initially and then to follow that up with an 
S1–S2 sequence. To identify LPs and DeEPs, the window of interest 
needs to be set at the terminal portion of the QRS to ensure that only 
the local EGM is annotated and the far-field activation is not tracked by 
the automated algorithm. If permitted by the system, annotation of the 
latest deflection of the local EGM is preferable (as this is easiest for an 
automated system to do consistently). Manual review of the automated 
annotations is often required to ensure precision.
Creation of S1 and S2 Maps
All mapping systems allow additional mapping on previously acquired 
signals. A practical method to compare the activation pattern of both 
maps would be to create the S2 map initially and then move the window 
of interest to the preceding S1, which is the final stimulus of the drive 
train to annotate the LPs.17 Automatic repetition of the pacing sequence 
Figure 3: In Silico Simulations of Decremental Response
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(c) Effect of communicating channels
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Factors influencing the extent of decrement in a simplified VT substrate demonstrated in an in silico model. A: Different pacing sites cause different degrees of DeEP. Conduction barriers 
placed between the pacing site and unexcitable scar led to a reduction in decrement (minimal DeEP, position 2). Pacing from other side of channel and near to the scar. When paced from 
proximity the extent of decrement was much higher (maximum DeEP, position 3). Pacing from the near end produced less decrement (mid DeEP, position 1). B: The third set of experiments 
included altering the size of central scar. See the reference scar size (B1). The bigger the scar (B2), the more the decrement (B3). C: Fewer open channels lead to maximal decrement. Pacing 
from close to unprotected channels with multiple side branches showed smaller decrement compared to a protected channel with no side branches. DeEP = decrement evoked potential. 
Source: Beheshti et al. 2018.11 Reproduced with permission from Elsevier.
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of the drive train followed by an extra stimulus while the substrate map 
is being performed would be the most time-efficient method.
Comparison of S1 and S2 Maps
The areas of DeEPs are usually a smaller subset of the areas with late 
potentials. This provides an opportunity to narrow the area of interest 
to the critical components of the VT circuit.
Manual Annotation of Late Potentials 
and Decrement-evoked Potentials
It goes without saying that, despite using automated algorithms, one has 
to verify the accuracy of the annotations during the S1 and S2 mapping 
to confirm the presence or absence of DeEPs. Another option is to 
manually annotate the local EGMs, which is less susceptible to errors 
and could provide accurate maps; however, this is time consuming.
Possible Application of Decrement-evoked 
Potential to Atrial Substrates
Haïssaguerre et al. showed pulmonary vein triggers to be frequent 
initiators of AF and this has led to the ablation strategy of pulmonary 
vein isolation.18 Although this had moved from ostial to antral lesion 
sets, it has remained the primary strategy for AF ablation up to the 
present time. Indeed, there is randomised data showing no additional 
benefit of ablation strategies with roof and mitral isthmus lines, or 
complex fractionated atrial EGM targeting in addition to pulmonary vein 
isolation in reducing the rate of recurrence of AF.19,20
The search for strategies to identify additional targets for AF ablation 
continues. Atrial myocardial thickness is less than one-third that of 
ventricular myocardium, at approximately 1–4  mm on average.21 
Surprisingly in this thin-walled tissue, there is evidence for electrical 
dissociation between layers of the atrial endo- and epicardium, as well 
as heterogeneity in conduction in different regions.22 Atrial arrhythmia 
is promoted by early functional and then structural changes in this 
tissue. Probably, the first known description of decrement preceding 
atrial re-entry was described by Lammers in 1992.7 This has been 
overlooked and needs further developmental work for application in 
the atrium using the DeEP protocol.
The application of DeEP mapping to atrial tissue shows promise. Indeed, 
there are published cases of successful intra-atrial re-entrant 
tachycardia (IART) ablation using DeEP mapping to locate involved 
tissue that corresponded with earliest activation but did not correspond 
with LPs mapped without the use of extra-stimulus pacing. The circuit 
Voltage map















S1/S2 from RVA (600/320 ms)
125 ms 151 ms
II
A B
A: Case example of a post-MI scar-related ventricular tachycardia showing right anterior oblique views of the electroanatomical maps. The voltage map shows a large area of low voltage at the 
anterolateral wall. The late potential map shows an extensive area of late activation into the low voltage region. In contrast, the DeEP map shows that the area of interest is much more 
circumscribed to the anteroseptal region of the left ventricle. This corresponds to the ventricular tachycardia isthmus of the tachycardia. ILAM mapping shows several areas with isochronal 
crowding, making it difficult to select the best ablation strategy. B: An example of a DeEP mapped with a decapolar catheter. DeEP = decrement evoked potential; ILAM = isochronal late 
activation mapping. Source: Porta-Sánchez et al. 2018.16 Reproduced with permission from Elsevier.
Figure 4: Mapping in Ischaemic Cardiomyopathy
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in IART may share characteristics with that in ventricular tachycardia 
given there are areas of fixed scar and routes for conduction within or 
around this.23 The lack of easily mappable, targetable, low-voltage areas 
in many cases of AF make functional mapping of the atrial substrate an 
appealing approach.
Regions participating in the initiation and/or perpetuation of AF outside 
the pulmonary veins are likely to display the properties of conduction 
delay, block and re-entry which can be identified by applying DeEP 
mapping to atrial tissue. Analogous to ventricular tissue, atrial tissue 
forming a critical part of the AF substrate may be identifiable with DeEP 
mapping.16 Recent studies have further explored the presence of endo-
epicardial dissociation seen in atrial tissue, which may be brought out 
to an even greater extent with extra-stimulus pacing.24,25 This functional 
change in atrial activation patterns is likely reflected in the difficulties 
shown mapping unstable atrial activation patterns in AF.26 DeEP 
mapping may play a role in unmasking the substrate that facilitates the 
chaotic, three-dimensional movement of wavefronts during AF. 
Comparison with Other Extrastimuli 
Strategies and Future Perspectives 
Since the first published description of decremental mapping for the 
facilitation of VT ablation in 2015, there have been three more published 
clinical series.6 Our group published our initial clinical experience with 
DeEP mapping for VT ablation in March 2018 and, in the same month, 
de Riva's group published their initial patient data, followed by Acosta’s 
group with their initial experience and a follow-up 2 years later.16,27–29 
Although these studies shared some similarities, there were important 
differences in methodology and ablation strategy (Table 1). 
The study by Acosta’s group included 37 patients, mostly post-infarction 
patients but one-quarter of these patients had other diagnoses, such as 
arrhythmogenic right ventricular dysplasia and dilated cardiomyopathy.29 
They referred to the decrementing potentials as ‘hidden slow conductions’ 
(HSCs). An HSC was defined as the local EGM that decremented a minimum 
of 10 ms with double extra stimuli during programmed stimulation. They 
chose the ventricular effective refractory period (VERP) + 60 ms on S
1
 and 
VERP + 40–20ms on S
2
. If block was observed, the coupling interval was 
prolonged until conduction occurred and, in situations of uncertainty 
(when conduction was not delayed), they added a third extrastimulus. With 
this relatively aggressive protocol, they managed to induce sustained VT in 
only three patients, and those were terminated with antitachycardia 
pacing or direct current cardioversion. This protocol is quite different from 
ours regarding both the number of extra-stimuli and the length of the 
coupling interval. 
Acosta et al. performed pacing only when a suspected HSC was seen 
and, in a third of those signals, they could confirm decrement. For a 
quarter of the signals, a
 
third stimulus was necessary to demonstrate 
decrement. They noticed HSCs in 57% of patients with a median of 
eight HSCs per patient. They observed more HSCs in ischaemic patients 
and in smaller scars with less late potentials, a feature noticed by 
others as well. In addition, they noted more HSCs in heterogenous 
scars than in large homogenous scars. Their ablation strategy was to 
target suspected channels using voltage mapping or as demonstrated 
by late potentials (LPs). 
In patients with HSCs, they added further ablation to these areas, which 
in the vast majority were outside the presumed channels and would 
have not been targeted by their standard ablation strategy. The patients 
with HSC ablation had shorter total RF times (17 minutes), presumably 
because of smaller scars and fewer LPs being surrogates for potential 
channels. More patients with HSC were rendered non-inducible after 
the initial ablation but, after further mapping and ablation, the results 
were similar at the end of the procedure as well as during follow-up. 
In the two other studies, a strategy that initially targeted the 
decrementing potentials was used, so it is difficult to tease out the 
potential added benefit of HSC ablation.28,29 As a complement to the 
electrical data, Acosta et al. also added some insight gained from MRI 
scans obtained before the procedure, and could demonstrate that the 
HSCs were located in areas in the dense scar or border zone, even 
though the EGM voltage was normal (>1.5 mV).29
A study on an extended cohort of patients with longer follow-up has 
been recently published by the same group and compared to a historical 
cohort; this has shown that targeting the HSC seems to be associated 
with less VT during follow-up.29
This is a feature noted by de Riva's group, who studied 62 post-
infarction patients referred for VT ablation.28 Two patients had to be 
excluded because they were intolerant to the pacing protocol. They 
Table 1: Studies Assessing the Functional Component of the Ventricular Tachycardia Substrate: 









DeEP16 20 patients with ICM One extrastimulus
VERP + 20ms
In 50% of DeEP areas 
co-localised with 
diastolic isthmus
Only DeEP High non-
inducibility (80%)
6 months: mean VT 
burden reduced to 0 from 
11 pre-procedure
HSC29 37 patients with
ICM, ARVC and DCM
2–3 extrastimuli
VERP + 60 ms, VERP + 
40–20 ms and VERP + 
10–20 ms
Majority in border zone 
areas, 32% in non-scar 
areas
Both LP and HSC, and 
compared to historical 




2 years: less VT 
recurrence (75% versus 
58%)
EDP28 62 patients with 
ICM
1–4 extrastimuli 50% in dense scar, 30% 
in border zone, 20% in 
non-scar area (hidden 
substrate)
Only EDP High non-
inducibility (90%)
16 months: low 
recurrence (22%)
ARVC = arrhythmogenic right ventricular dysplasia; DCM = dilated cardiomyopathy; DeEP = pecrement-evoked potential; EDP = evoked delayed potential; HSC = hidden slow conduction; 
LP = late potential; VERP = ventricular effective refractory period; VT = ventricular tachycardia.
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mapped the infarct area with a pacing protocol of S
1 
= 500 ms and set 
S
2
 at VERP + 50 ms. They targeted ablation signals that showed a near-
field component that was <1.5 mV and displayed decrement or block 
with the pacing protocol. Late potentials that did not display these 
findings were not targeted for ablation. In their study, a third of all 
signals from the infarct area were decrementing and were termed 
‘evoked delayed potentials’ (EDPs); about 20% of those were in 
normal voltage areas adjacent to the scar. All but four (7%) patients 
displayed EDPs. 
The authors had MRI data for a small subset of patients, and observed 
that the EDPs came from areas with relatively normal voltage and were 
mostly located in non-transmural scar areas. On average, they ablated 
only for 15 minutes with a rigorous endpoint of loss of capture at that 
site. Almost 70% of patients were non-inducible after EDP ablation only, 
and an additional 23 were non-inducible after further ablation based on 
conventional mapping.
Our protocol and study differed significantly from other studies in 
several aspects:
• A simple pacing (S
1 
= 600 ms) and extra-stimulus protocol (S
2 
= VERP 
+ 20 ms) were used.
• Multielectrode catheters were used in 80% of the cases.
• DeEP mapping was performed only in areas with late potentials.
• Mechanistic evidence of the value of DeEP mapping was provided 
by demonstrating that in 50% of patients (13 VTs), DeEP areas and 
not LPs correlated well with the diastolic pathway of the VT circuit. 
The abolition of this resulted in better clinical results.
DeEP mapping, regardless of the protocol chosen, will be invaluable in 
cases where VT induction is either impossible or not feasible. 
Multielectrode catheters will be increasingly be used in these 
circumstances and this will facilitate the procedure further; this may 
also elucidate targets in the vicinity of the mapped area as critical areas 
for successful ablation. Attempts are under way to automate and 
incorporate this concept into contemporary 3D mapping technology 
with multi-electrode catheters. 
Conclusion
DeEP mapping is a substrate-based mapping strategy established on 
the foundation of robust mechanistic evidence and has been 
prospectively validated in a multi-centre human trial. 
This functional assessment of the VT substrate adds to the conventional 
mapping of local abnormal EGMs during VT ablation. Unlike local 
abnormal EGMs, however, DeEP sites have been proven to participate 
in initiation and maintenance of re-entrant arrhythmias, which obviates 
the need for extensive substrate ablation. 
The evidence for the efficacy of this strategy in VT ablation comes from 
a multicentre patient cohort, but further validation in larger randomised 
trials with automated software in 3D mapping systems will be important. 
The utility of DeEP mapping in atrial flutter and AF ablation is still to be 
elucidated and such efforts are under way. 
Clinical Perspective
• Decrement-evoked potential (DeEP) mapping is a strategy for VT 
ablation without inducing VT. 
• If tachycardia remains inducible after DeEP, other methods of 
substrate ablation can be explored. 
• Automated algorithm incorporation into electro-anatomical 
mapping systems could allow DeEP mapping to integrate into 
the workflow seamlessly. 
• In AF ablation and atypical atrial flutters, DeEPs could be targeted 
where they identify the tachycardia isthmus or at areas capable 
of local re-entry, without time-consuming extensive mapping 
and annotation.
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